2006 to Present
`
`
`
`1994 -2006
`
`Ivan T. Hofmann, C.P.A., C.F.F., C.L.P.
`Curriculum Vitae
`
`
`
`Professional History
`
`Gleason IP, a division of Gleason & Associates, P.C. – Managing Director/Shareholder
`
`Ivan Hofmann is a managing director and shareholder at Gleason IP. He has years of professional experience
`with a deep specialization in complex intellectual property matters. Mr. Hofmann's IP expertise includes
`extensive litigation support and testifying experience in quantifying financial damages related to patent
`infringement and other intellectual property issues, as well as breach of contract claims, class action law suits and
`other litigation-related matters. His experience includes using statistical, financial, and economic analysis and
`models related to various technical issues. He provides value-added services in all phases of litigation in various
`capacities, including assistance with discovery, depositions, expert opinions, and testimony during trial.
`
`Mr. Hofmann's experience with intellectual property matters includes false advertising cases, theft of trade
`secrets, and trademark infringement matters. He has performed analysis of irreparable harm in preliminary
`injunction hearings and regularly performs analysis of commercial success in connection with secondary
`considerations of nonobviousness. Mr. Hofmann has experience with intellectual property issues in numerous
`industries, including extensive experience in the pharmaceutical industry.
`
`As a Certified Licensing Professional (CLP), Mr. Hofmann has demonstrated knowledge and experience in
`analyzing license agreements and royalty terms. He assists companies in licensing negotiations with economic
`analysis in licensing agreements. He also has performed royalty audits on behalf of universities and corporations.
`Mr. Hofmann’s extensive knowledge of licensing is useful in his analysis of reasonable royalties in patent
`infringement cases.
`
`Also, Mr. Hofmann has experience in the areas of accounting, auditing, forensic accounting, fraud investigations
`and due diligence work. He has been involved in matters in state and federal courts, as well as domestic and
`international arbitration and other forums for dispute resolution. His experience includes matters with public and
`private companies in a broad range of industries including pharmaceuticals, communications, health care,
`manufacturing, retail, oil and gas, coal, utilities, land development, hospitality, and others.
`
`Deloitte & Touche LLP – Senior Manager
`
`Mr. Hofmann was a senior manager with the global firm of Deloitte & Touche LLP in the Forensic and Dispute
`Services and Assurance and Advisory services departments. He served numerous clients in various industries
`ranging in size from small, privately held companies to large, multi-national Fortune 500 companies.
`
`Education and Certification
`
`Bachelor of Business Administration, double major in Accounting and Economics, Magna Cum Laude,
` University of Notre Dame, 1994
`Certified Public Accountant, Pennsylvania 1996
`Certified in Financial Forensics, 2008
`Certified Licensing Professional 2010
`
`Professional and Business Affiliations
`
`American Institute of Certified Public Accountants, Member
`Pennsylvania Institute of Certified Public Accountants, Member
`Licensing Executives Society, Member
`
`Civic Affiliations
`
`Notre Dame Club of Pittsburgh
`
`
`
`
`Gleason IP, a division of Gleason & Associates, P.C. One Gateway Center, Suite 525 420 Fort Duquesne Boulevard Pittsburgh, PA 15222
`
`BOM Exhibit 1019
`BOM v. Nidec
`IPR2014-01121
`
`1
`
`

`
`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases in which Mr. Hofmann has testified
`at deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`
`
`
`
`Jazz Pharmaceuticals, Inc. v. Roxane Laboratories, Inc. – United States District Court for the
`District of New Jersey, 2015 (Deposition)
`
`Apotex Corp. v. ViiV Healthcare Co. and ViiV Healthcare UK LTD. – United States Patent Trial
`and Appeal Board, 2015 (Deposition, Declaration)
`
`Endo Pharmaceuticals, Inc. v. Roxane Laboratories, Inc. (13-cv-03288), Endo Pharmaceuticals Inc.
`v. Ranbaxy Laboratories LTD., Ranbaxy Inc. and Ranbaxy Pharmaceuticals Inc. (13-cv-04343),
`Endo Pharmaceuticals Inc. v. Ranbaxy Laboratories LTD., Ranbaxy Inc., and Ranbaxy
`Pharmaceuticals, Inc. (13-cv-08597), Endo Pharmaceuticals Inc. and Grunenthal GmBH v. Teva
`Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. (13-cv-08060), Endo Pharmaceuticals Inc.
`and Grunenthal GmBH v. Impax Laboratories, Inc. and Thorx Laboratories, Inc. (12-cv-8317), Endo
`Pharmaceuticals Inc. and Grunenthal GmBH v. Impax Laboratories, Inc. (13-cv-435), Endo
`Pharmaceuticals, Inc. v. Actavis Inc. and Actavis South Atlantic LLC (12-cv-8985), Endo
`Pharmaceuticals Inc. and Grunenthal GmBH v. Actavis Inc., Actavis South Atlantic, LLC and
`Watson Pharmaceuticals, Inc. (13-cv-0436 ), and Endo Pharmaceuticals Inc. and Grunenthal GmBH
`v. Amneal Pharmaceuticals, LLC and Amneal Pharmaceuticals of New York, LLC (12-cv-8115) –
`United States District Court for the Southern District of New York, 2015 (Trial)
`
`Otsuka Pharmaceutical Co., Ltd. v. Alembic Pharmaceuticals Limited, Alembic Limited, Alembic
`Global Holdings SA, and Alembic Pharmaceuticals Inc. – United States District Court for the
`District of New Jersey, 2015 (Temporary Restraining Order Hearing)
`
`Kangaroo Media, Inc. and Immersion Entertainment, LLC v. YinzCam, Inc. – United States District
`Court for the Western District of Pennsylvania, 2015 (Deposition)
`
`Endo Pharmaceuticals, Inc. v. Roxane Laboratories, Inc. (13-cv-03288), Endo Pharmaceuticals Inc.
`v. Ranbaxy Laboratories LTD., Ranbaxy Inc. and Ranbaxy Pharmaceuticals Inc. (13-cv-04343),
`Endo Pharmaceuticals Inc. v. Ranbaxy Laboratories LTD., Ranbaxy Inc., and Ranbaxy
`Pharmaceuticals, Inc. (13-cv-08597), Endo Pharmaceuticals Inc. and Grunenthal GmBH v. Teva
`Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. (13-cv-08060), Endo Pharmaceuticals Inc.
`and Grunenthal GmBH v. Impax Laboratories, Inc. and Thorx Laboratories, Inc. (12-cv-8317), Endo
`Pharmaceuticals Inc. and Grunenthal GmBH v. Impax Laboratories, Inc. (13-cv-435), and Endo
`Pharmaceuticals Inc. and Grunenthal GmBH v. Sandoz Inc. (12-cv-8318) – United States District
`Court for the Southern District of New York, 2015 (Deposition)
`
`Intendis GmBH, Intraserv GmBH & Co. KG, and Bayer Healthcare Pharmaceuticals, Inc. v.
`Glenmark Generics Limited and Glenmark Generics, Inc. USA – United States District Court for the
`District of Delaware, 2015 (Trial)
`
`1
`
`
`
`2
`
`

`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`
`
`2
`
`
`Shire Development LLC, Shire Pharmaceutical Development Inc., Cosmo Technologies Limited,
`and Nogra Pharma Limited, v. Cadila Healthcare Limited (d/b/a Zydus Cadila) and Zydus
`Pharmaceuticals (USA) Inc. – United States District Court for the District of Delaware, 2014
`(Deposition)
`
`Millenium Pharmaceuticals, Inc. v. Accord Healthcare, Inc., Actavis LLC f/k/a Actavis Inc., and
`Sandoz, Inc. – United States District Court for the District of Delaware, 2014 (Trial)
`
`Merck Eprova AG v. Gnosis S.P.A. and Gnosis Bioresearch S.A. – United States District Court for
`the Southern District of New York, 2014 (Declaration)
`
`Intendis GmBH, Intraserv GmBH & Co. KG, and Bayer Healthcare Pharmaceuticals, Inc. v.
`Glenmark Generics Limited and Glenmark Generics, Inc. USA – United States District Court for the
`District of Delaware, 2014 (Deposition)
`
`Laboratorios Silanes, S.A. De C.V., Instituto Bioclon, S.A. De C.V. and Rare Disease Therapeutics,
`Inc. v. BTG International, Inc. – United States Patent Trial and Appeal Board, 2014 (Declaration)
`
`Millenium Pharmaceuticals, Inc. v. Accord Healthcare, Inc., Actavis LLC f/k/a Actavis Inc., and
`Sandoz, Inc. – United States District Court for the District of Delaware, 2014 (Deposition)
`
`Pfizer, Inc., Wyeth, LLC, Wyeth Pharmaceuticals, Inc., PF Prism, CV v. Apotex, Inc., Apotex Corp.,
`Breckenridge Pharmaceuticals, Inc., Alembic Pharmaceuticals Ltd., Lupin LTD, Lupin
`Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., Mylan, Inc., Roxane Laboratories, Inc., Sandoz,
`Inc., Watson Laboratories, Inc. Florida, Wockhardt LTD., Wockhardt USA, LLC, Zydus
`Pharmaceuticals (USA), LLC, and Cadila Healthcare Limited – United States District Court for the
`District of Delaware, 2014 (Deposition)
`
`Apotex, Inc. and Apotex Corp. vs. Acorda Therapeutics, Inc. – United States District Court for the
`Southern District of New York, 2014 (Deposition)
`
`Drawbridge Special Opportunities Fund LP and Fortress Value Recovery Fund I LLC f/k/a D.B.
`Zwirn Special Opportunities Fund, L.P. v. PRC Williston LLC – In the Court of Chancery of the
`State of Delaware, 2014 (Preliminary Injunction Hearing, Deposition)
`
`Shire LLC, Shire Development, Inc., and Shire Development, LLC v. Amneal Pharmaceuticals,
`LLC, Roxane Laboratories, Inc., Sandoz, Inc., Mylan, Inc., Mylan Pharmaceuticals, Inc., Actavis,
`Inc., Actavis, LLC, Actavis Elizabeth LLC, Johnson Matthey, Inc., and Johnson Matthey
`Pharmaceuticals Materials – United States District Court for the District of New Jersey, 2014
`(Deposition)
`
`
`
`3
`
`

`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`
`
`3
`
`
`Gnosis S.P.A., Gnosis Bioresearch S.A., and Gnosis U.S.A., Inc. v. South Alabama Medical Science
`Foundation and Gnosis S.P.A., Gnosis Bioresearch S.A., and Gnosis U.S.A., Inc. v. Merck & Cie –
`United States Patent Trial and Appeal Board, 2013 (Deposition)
`
`Warner Chilcott Company, LLC v. Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare
`Limited (d/b/a Cadila Healthcare) – United States District Court for the District of Delaware, 2013
`(Deposition)
`
`Genentech, Inc. and Roche Palo Alto, LLC v. Sandoz, Inc. – United States District Court for the
`Northern District of California, San Francisco, 2013 (Deposition)
`
`Genentech, Inc. and Roche Palo Alto, LLC v. Apotex, Inc. – United States District Court for the
`Northern District of California, San Francisco, 2013 (Deposition)
`
`Grant Street Group, Inc. v. RealAuction.com, LLC – United States District Court for the Western
`District of Pennsylvania, 2013 (Trial)
`
`The Medicines Company v. Mylan, Inc., Mylan Pharmaceuticals, Inc., and Bioniche Pharma USA,
`LLC, United States District Court for the Northern District of Illinois, 2013 (Deposition)
`
`Sloan Valve Company v. Zurn Industries, Inc. and Zurn Industries, LLC – United States District
`Court for the Northern District of Illinois, Eastern Division, 2013 (Deposition)
`
`Medicis Pharmaceutical Corporation and Dow Pharmaceutical Sciences, Inc. v. Actavis Mid
`Atlantic, LLC – United States District Court for the District of Delaware, 2013 (Deposition)
`
`Medicis Pharmaceutical Corporation v. Actavis Mid Atlantic, LLC and Actavis, Inc. – Superior
`Court of Arizona, County of Maricopa, 2012 (Deposition)
`
`Shire Development Inc., Shire Pharmaceutical Development Inc., Cosmo Technologies Limited, and
`Giuliani International Limited, v. Cadila Healthcare Limited (d/b/a Zydus Cadila) and Zydus
`Pharmaceuticals (USA) Inc. – United States District Court for the District of Delaware, 2012
`(Deposition)
`
`Medicis Pharmaceutical Corporation v. Actavis Mid Atlantic, LLC and Actavis, Inc. – Superior
`Court of Arizona, County of Maricopa, 2012 (Temporary Restraining Order Hearing)
`
`Sciele Pharma, Inc., Andrx Corporation, Andrx Pharmaceuticals, Inc. (N/K/A Watson Laboratories,
`Inc.-Florida), Andrx Pharmaceuticals, L.L.C., Andrx Laboratories (NJ), Inc. Andrx EU LTD, and
`Andrx Labs, L.L.C. v. Lupin LTD. And Lupin Pharmaceuticals, Inc. – United States District Court
`District of Delaware, 2011 (Preliminary Injunction Hearing)
`
`
`4
`
`

`
`Ivan T. Hofmann CPA/CFF, CLP
`Cases which Mr. Hofmann has testified at
`deposition or at trial in the past four years.
`
`LIST OF CASES PURSUANT TO 26(a)(2)(B)
`
`
`
`
`
`4
`
`
`Merck Eprova AG v. Brookstone Pharmaceuticals, LLC a/k/a Acella Pharmaceuticals, LLC, Harold
`Arthur Deas, and Thomas Jeffrey Bryant – United States District Court Southern District of New
`York, 2011 (Trial)
`
`Grant Street Group, Inc. v. RealAuction.com, LLC – United States District Court Western District of
`Pennsylvania, 2011 (Depositions)
`
`Merck Eprova AG v. Brookstone Pharmaceuticals, LLC a/k/a Acella Pharmaceuticals, LLC, Harold
`Arthur Deas, and Thomas Jeffrey Bryant – United States District Court Southern District of New
`York, 2011 (Deposition)
`
`In the Matter of the Arbitration Between Par Pharmaceutical, Inc. and MiddleBrook
`Pharmaceuticals, Inc. – American Arbitration Association, 2011 (Hearing)
`
`Sanofi-Aventis Deutschland GMBH, Aventis Pharma S.A., Abbott GMBH & Co. Kg, and Abbott
`Laboratories v. Glenmark Pharmaceuticals Inc., USA, and Glenmark Pharmaceuticals Ltd. – United
`States District Court for New Jersey, 2011 (Trial)
`
`5